Universal Vision Biotechnology Co., Ltd. (TPEX: 3218)
217.50
+5.00 (2.35%)
Sep 10, 2024, 1:30 PM CST
Universal Vision Biotechnology Cash Flow Statement
Financials in millions TWD. Fiscal year is January - December.
Millions TWD. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | 2018 - 2014 |
---|---|---|---|---|---|---|---|
Period Ending | Jun '24 Jun 30, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | Dec '19 Dec 31, 2019 | 2018 - 2014 |
Net Income | 1,101 | 1,045 | 850.53 | 595.43 | 483.21 | 238.01 | Upgrade
|
Depreciation & Amortization | 473.26 | 441.77 | 367.85 | 315.1 | 260.46 | 242.89 | Upgrade
|
Other Amortization | 3.99 | 4.38 | 4.41 | 4.42 | 3.5 | 2.12 | Upgrade
|
Loss (Gain) From Sale of Assets | 0.86 | 1.37 | 2.22 | 0.22 | -3.28 | -4.07 | Upgrade
|
Loss (Gain) From Sale of Investments | - | - | - | - | - | -0.03 | Upgrade
|
Provision & Write-off of Bad Debts | 0.81 | 4.36 | 7.65 | 0.32 | 0.01 | -0.2 | Upgrade
|
Other Operating Activities | 37.92 | 65.66 | 83.06 | 38.42 | 45 | -42.8 | Upgrade
|
Change in Accounts Receivable | -43.73 | -6.76 | -54.54 | -158.12 | -35 | -23.74 | Upgrade
|
Change in Inventory | -27.78 | -89.85 | -111.63 | -47.32 | -1.27 | -2.16 | Upgrade
|
Change in Accounts Payable | -29.88 | 57.76 | 44.06 | 87.56 | 46.46 | 14.35 | Upgrade
|
Change in Other Net Operating Assets | 26.71 | 29.82 | 74.57 | 75.74 | 27.98 | -5.19 | Upgrade
|
Operating Cash Flow | 1,543 | 1,554 | 1,268 | 911.77 | 827.08 | 419.18 | Upgrade
|
Operating Cash Flow Growth | 8.99% | 22.51% | 39.09% | 10.24% | 97.31% | 53.51% | Upgrade
|
Capital Expenditures | -422.07 | -472.53 | -489.7 | -324.44 | -295.15 | -235.19 | Upgrade
|
Sale of Property, Plant & Equipment | 0.18 | 0.08 | 0.12 | 0.07 | 11.9 | 4.83 | Upgrade
|
Cash Acquisitions | - | - | - | - | -8.16 | - | Upgrade
|
Sale (Purchase) of Intangibles | -0.62 | -1.68 | -3.14 | -4.26 | -3.36 | -4.14 | Upgrade
|
Investment in Securities | 196.92 | -1.74 | -70.81 | -44.06 | -122.78 | 11.73 | Upgrade
|
Other Investing Activities | -1.25 | -1.08 | -1.14 | -7.11 | -1.66 | -0.62 | Upgrade
|
Investing Cash Flow | -226.85 | -476.95 | -564.66 | -379.81 | -419.2 | -223.38 | Upgrade
|
Short-Term Debt Issued | - | 8.85 | - | - | 100 | - | Upgrade
|
Long-Term Debt Issued | - | - | - | 23.88 | - | - | Upgrade
|
Total Debt Issued | 15.07 | 8.85 | - | 23.88 | 100 | - | Upgrade
|
Short-Term Debt Repaid | - | - | - | -176.49 | - | -70 | Upgrade
|
Long-Term Debt Repaid | - | -177.84 | -164.22 | -140.03 | -117.37 | -117.58 | Upgrade
|
Total Debt Repaid | -179.38 | -177.84 | -164.22 | -316.52 | -117.37 | -187.58 | Upgrade
|
Net Debt Issued (Repaid) | -164.31 | -168.99 | -164.22 | -292.64 | -17.37 | -187.58 | Upgrade
|
Common Dividends Paid | -1,073 | -479.58 | -380.62 | -319.72 | -152.25 | -95.15 | Upgrade
|
Other Financing Activities | -134.24 | -62.09 | 5 | 0.03 | 5 | -0.01 | Upgrade
|
Financing Cash Flow | -1,371 | -710.65 | -539.83 | -612.33 | -164.62 | -282.74 | Upgrade
|
Foreign Exchange Rate Adjustments | 20.35 | -6.46 | 5.14 | -1.45 | 0.61 | -7.28 | Upgrade
|
Net Cash Flow | -34.38 | 359.53 | 168.83 | -81.81 | 243.87 | -94.21 | Upgrade
|
Free Cash Flow | 1,121 | 1,081 | 778.47 | 587.33 | 531.93 | 184 | Upgrade
|
Free Cash Flow Growth | 15.35% | 38.87% | 32.54% | 10.41% | 189.10% | 169.49% | Upgrade
|
Free Cash Flow Margin | 26.92% | 26.48% | 22.28% | 22.32% | 25.91% | 12.97% | Upgrade
|
Free Cash Flow Per Share | 13.20 | 12.73 | 9.17 | 6.92 | 6.27 | 2.17 | Upgrade
|
Cash Interest Paid | 2.51 | 1.47 | 1.21 | 2.47 | 3.78 | 3.03 | Upgrade
|
Cash Income Tax Paid | 251.5 | 220.7 | 165.62 | 132.78 | 77.82 | 71.51 | Upgrade
|
Levered Free Cash Flow | 382.18 | 820.41 | 574.26 | 411.54 | 410.63 | 121.74 | Upgrade
|
Unlevered Free Cash Flow | 392.68 | 830.3 | 582.73 | 419.77 | 417.46 | 129.35 | Upgrade
|
Change in Net Working Capital | 508.48 | -38.46 | -27.61 | 51.39 | -79.18 | 30.74 | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.